Introduction
Patients who present with a principal complaint of disabling fatigue of uncertain cause have received much attention in recent years. Correspondingly there has been an increasing amount of research into this problem. The findings have however often been contradictory. Resolution of these contradictions depends on the ability to compare research studies, but such constructive comparison has rarely been possible. This is largely because research has been carried out by investigators trained in different disciplines, using different criteria to define the condition. Whilst such an eclectic approach is to be welcomed, agreement on case definition, and assessment methods is necessary if progress is to be made.
The principal lack of agreement concerns definition of the clinical syndrome to be studied. A number of clinical syndromes have been described, all apparently referring to similar groups of patients, but differing sufficiently to preclude comparison of published studies. The various names used include epidemic neuromyasthenia 1 , idiopathic chronic fatigue and myalgia syndrome-, benign myalgic encephalomyelitis'', chronic infectious mononucleosis', Royal Free disease", postviral fatigue syndrome", fibrositis-fibromyalgtai-", and chronic fatigue syndrome".
An attempt to address the problem of case definition was made by Holmes and colleagues in 1988 9 , who chose the name chronic fatigue syndrome (CFS) because it is descriptive and free from unproven aetiological implications. They also proposed an operational definition for the syndrome. Although a welcome advance, this definition proved to be unsatisfactory in practice'P-". Other definitions eg by Lloyd and colleagues'f are also unsatisfactory':', and have not been widely accepted.
Additional sources of difficulty have arisen from inadequate and poorly described sampling procedures, choice of comparison groups, shortcomings in study design, and measures of poor or unspecified reliability!".
In an attempt to remove these obstacles to progress, a meeting of research workers with a known interest in the field was convened. The format of the meeting was modelled on the MRC workshop on Alzheimer's disease";
Aims
The aim of the meeting was to seek agreement amongst research workers on recommendations for the conduct and reporting of future studies of patients with chronic fatigue. Specifically we set out to agree on which patients should be included, how such studies should be approached, and on the minimal data that should be reported.
Procedure
The meeting (attended by all those listed at the beginning of the paper) was held at Green College, Oxford, on 23 March 1990, and chaired by Professor Anthony Clare. It was restricted to invited research workers, all of whom had studied patients with CFS. The disciplines represented included biochemistry, general medicine, general practice, imaging, immunology, infectious diseases, microbiology, neurology, physiology, psychiatry, and psychology.
Before the meeting all participants (and several others who were unable to attend) were circulated with a questionnaire, and their responses used to draw up an initial discussion document which formed the basis of discussion during the meeting. Points on which agreement was reached were recorded and a draft of this paper circulated to participants.
The Guidelines
The following guidelines were agreed.
Symptoms
A preliminary research glossary is appended. This comprises definitions for symptoms and suggestions for their description.
Signs
There are no clinical signs characteristic of the condition, but patients should be fully examined, and the presence or absence of signs reported.
Syndromes
Two broad syndromes can be defined: 
Post-infectious fatigue syndrome (PIFS)
This is a subtype of CFS which either follows an infection or is associated with a current infection (although whether such associated infection is of aetiological significance is a topic for research).
To meet research criteria for PIFS patients must (i) fulfil criteria 'for CFS as defined above, and (ii) should also fulfil the following additional criteria: (a) There is definite evidence of infection at onset or presentation (a patient's self-report is unlikely to be sufficiently reliable). In reporting studies it should be clearly stated which of these two syndromes is being studied. The degree of disability should be measured and stated. The criteria and method used to exclude subjects from study must be clearly described and the degree of examination and investigation specified. All patients should be assessed for associated psychiatric disorder and the results of this assessment reported.
Sampling
The way in which the patient sample was obtained should be clearly described. In particular it is essential to know whether the sample was recruited from primary care or from secondary referral centres. Because of the risk of introducing bias at this stage the use of random samples or consecutive referrals is preferred.
Comparison groups
The term comparison group is preferred to control group. The precise choice of comparison groups should be determined by the hypothesis being tested. In the current state of knowledge multiple comparison groups may be required, as there are pitfalls in the sole use of 'healthy' or 'normal' selected controls.
Suggested comparison groups include patients with neuromuscular disorder, patients with conditions causing inactivity, and patients with depressive disorder. The method used to obtain the comparison group should be clearly specified.
Study design
The design of studies must be chosen with regard to the hypothesis being tested. Both cross-sectional and longitudinal designs may be useful; the former to establish associations; and the latter to demonstrate temporal sequence (eg of infection and symptoms).
Longitudinal single case designs that examine correlations of relevant variables with fluctuations in symptom severity may be useful.
Measurements
All measures (both clinical and laboratory based) should be reliable, valid, and reproducible between centres.
Reliable measures of subjective fatigue and of disability are lacking and require development. When reporting studies the reliability of all measures should be assessed and specified whenever possible.
Glossary
This glossary provides provisional definitions of the principal symptoms and suggests how they may be described. Each symptom is considered as follows:
(i) A description of the symptom (what it is). (ii) What it is to be distinguished from (what it is not). (iii) Criteria for rating its presence. (iv) Additional description.
Fatigue
(i) When used to describe a symptom this is a subjective sensation and has a number of synonyms including, tiredness and weariness. A clear description of the relationship of fatigue to activity is preferred to the term fatiguability. Two aspects of fatigue are commonly reported: mental and physical. Mental fatigue is a subjective sensation characterized by lack of motivation and of alertness. Physical fatigue is felt as lack of energy or strength and is often felt in the muscles. (iv) The symptom should be described as follows: (a) severity: mild, moderate. or severe; (b) frequency: continuous or intermittent. If intermittent the proportion of the time present; (c) relation to activity: it should be stated whether the fatigue is greatly increased by minor exertion and whether it occurs at rest.
Disability
(i) This refers to any restriction or lack (resulting from loss of psychological or physiological function) of ability to perform an activity in the manner or within the range considered normal for a human being (ie things people cannot do in the areas of occupational, social, and leisure activities because of their illness'P), (iii) There should be a definite and persistent change from a previous level offunctioning and it is desirable to seek supportive evidence from an informant.
(iv) The disability should be described as follows: (a) area of disability (ie occupational, social, leisure, self care); (b) degree of disability.
Mood disturbance (i) The term mood disturbance has been used to include depression, loss of interest and loss of pleasure (anhedonia), anxiety, emotional lability and irritability.
(ii) These phenomena should be distinguished from each other.
(iii) To be regarded as a symptom the mood disturbance should be (a) complained of; (b) should represent a significant change from a previous state; and (c) should be relatively persistent or recurrent. Judgements of the appropriateness of mood disturbance are unreliable and should be avoided.
(iv) The symptom should be described as follows: (a) type: depressed mood, anhedonia, anxious mood, emotional lability, irritability; (b) severity: standard scales are available to assess the severity of depressed mood and anxiety. In addition it should be determined whether the patient's disorder is sufficient to meet operational diagnostic criteria for major depressive disorder, generalized anxiety disorder or panic disorder according to a recognized psychiatric classification, eg the current edition of the Diagnostic and Statistical Manual of the American Psychiatric Association, DSM-III-R17; (c) duration and frequency of the mood disturbance should be reported.
Myalgia
(i) This refers to the symptom of pain or aching, felt in the muscles.
(ii) It should be distinguished from feelings of weakness and from pain felt in other areas such as joints.
(iii) The myalgia should be (a) complained of; (b) be disproportionate to exertion; (c) be a change from a previous state; (d) should be persistent or recurrent.
(iv) The symptom should be described as follows: (a) severity: mild, moderate, or severe; (b) frequency and duration; (c) relation to exertion: if after exertion the time of onset relative to the exertion, and duration should be described.
Sleep disturbance (i) The symptom of sleep disturbance refers to a subjective report of a change in the duration or quality of sleep. (iv) The symptom should be described as follows: (a) type: hypersomnia or increased sleep; insomnia or reduced sleep (which should be further described as either difficulty getting off to sleep, early waking, or subjectively disturbed or unrefreshing sleep); (b) severity: the amount of change in duration of sleep should be quantified in hours.
